SCHEMBL9442002

SCHEMBL9442002

OC(c1ccccc1)C1CCCCN1CC1CC1

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4589105 0.84 LMNA (0.49) LMNA
SCHEMBL10587075 0.82 LMNA (0.61) LMNA
SCHEMBL1795967 0.80 LMNA (0.43) LMNA
SCHEMBL1795969 0.80 LMNA (0.43) LMNA
SCHEMBL11309797 0.78 KDM4E (0.47)
SCHEMBL11311855 0.78 SLC6A1 (0.45) LMNA
SCHEMBL5069171 0.77 LMNA (0.48) LMNA
SCHEMBL5069168 0.77 LMNA (0.48) LMNA
SCHEMBL5067551 0.77 LMNA (0.48) LMNA
SCHEMBL4622794 0.77 LMNA (0.48) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0572449-A1 (AMIDOMETHYL)NITROGEN HETEROCYCLIC ANALGESICS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-12-08 EP disclosed
US-5254569-A Side effect reduction; diuretics; anticonvulsants THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-10-19 US disclosed
WO-1992012128-A1 (AMIDOMETHYL)NITROGEN HETEROCYCLIC ANALGESICS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-07-23 WO disclosed